Select Page

Fashionably Fighting Multiple Sclerosis at NY Fashion Week

Updated on Nov 21, 2024 | Featured

During New York Fashion Week, hundreds of attendees gathered for Project Lab Coat—a showcase of custom-designed, colorful lab coats created and designed by Anthony Rosa, founder and CEO of Runway 7 Fashion, a Fashion Week production company. More than 30 faculty, staff, patients, and families from The Corinne Goldsmith Dickinson Center for Multiple Sclerosis at the Icahn School of Medicine at Mount Sinai attended the event, hosted by Runway 7 Fashion on Saturday, September 7, at Sony Hall in Times Square.

 

“We created Project Lab Coat to use our platform of Runway 7 Fashion for a greater cause,” said Mr. Rosa, who also serves on the Center’s Advisory Board. “The goal of the Project is fighting multiple sclerosis. It’s a first in many ways for us and could be a model for fighting additional important health battles—cancer, Lyme disease, or others. Our slogan is ‘Project Lab Coat at New York Fashion Week with Mount Sinai… Elevating awareness, fashionably fighting against multiple sclerosis, and uniting for a cause that truly matters.’”

In memory of his late brother, Ralph, who battled multiple sclerosis for 23 years, Mr. Rosa designed fashionable lab coats to raise multiple sclerosis awareness. In a unique touch, Mr. Rosa enlisted doctors, nurse practitioners, and families from the Center to model the coats. Amid a thumping soundtrack by DJ Tone Experience, staff from the Center and professional models alike took to the runway, spinning, strutting, and creating an atmosphere that was both lively and emotional.

Ilana Katz Sand, MD

Before the models began their runway walk, Elizabeth Rosa, mother of Mr. Rosa and Ralph, presented Fred Lublin, MD, Saunders Family Professor of Neurology at Icahn Mount Sinai and Director of the Center, with a $25,000 donation to support the Center’s critical work.

Walking the runway to support the cause were Ilana Katz Sand, MD; Stephen Krieger, MD; James Sumowski, PhD; Sammita Satyanarayan, MD; Sarah Levy, PhD; and Nurse Practitioner Gretchen Mathewson, alongside administrative staffer Lady Navia and research coordinator Claire Wigley, and several professional models. Adding a family touch, Michelle Fabian, MD’s daughter Julia Fabian, Fred Lublin, MD’s granddaughter Avery Lublin, and Social Worker Ilona Silva Alvarez’s daughter Isabella Veliz-Silva also joined.

“All of us at the Center are deeply appreciative of the remarkable and unique opportunity that Anthony Rosa has afforded us in raising awareness of multiple sclerosis and the Center, and in raising needed funds for our goals,” said Dr. Lublin. “I was especially appreciative of having my granddaughter, Avery Lublin, walk the runway and model Anthony’s reimagining of the laboratory coat.”

Stephen Krieger, MD, FAAN

Ilana Katz Sand, MD, Associate Professor of Neurology, Icahn Mount Sinai, and a physician from the Center who walked the runway, shared her experience. “Participating in the fashion show was an amazing experience. Although I was completely terrified while we were standing backstage, I looked around at my wonderful colleagues and was reminded how fortunate I am to be surrounded by such dedicated and caring professionals. We were all there to raise awareness and resources for the Center and all people living with multiple sclerosis; this inspired me to step out onto the runway with my head held high. We are extremely grateful to Anthony for this incredible opportunity and his generous support.”

For Stephen Krieger, MD, FAAN, Professor of Neurology, Icahn Mount Sinai, the evening also meant getting a little uncomfortable. “I was thrilled—terrified, actually—to walk the runway at Fashion Week to support the Center and the Mount Sinai Community,” he said. “It was fun to step out of my comfort zone for the cause. My lab coat said, ‘Find the Cure for MS: Someone I Love is Waiting.’ I think this is an incredible message, our north star at the Center, where we focus every day on both caring for our patients and making advancements in the field.”

The event offered a space not only to enjoy the fashion show but also to connect and celebrate with each other. Attendees from the Center had reserved tables to relax, catch up over drinks and appetizers hosted by Runway 7 Fashion, and cheer on their colleagues as they showed off these meaningful designs.

“A heartfelt thank you to Mr. Rosa and Runway 7 Fashion for creating such a memorable night and for their unwavering support of the Center’s dedicated staff and their work,” said Dr. Lublin.

A Place Designed to Help Women Be Healthy: Carolyn Rowan

Updated on Nov 20, 2024 | Featured

Carolyn Rowan focused her attention on women’s health when she realized she could help future generations of women to experience a lifetime of well-being in mind and body. Thus the vision for the Rowan Women’s Health Center at Mount Sinai emerged, with plans to open in 2025 on the northwest corner of 99th Street and Madison Avenue in the heart of the Upper East Side. The Rowan Center will elevate women’s health care to a level of luxury by bringing together women’s health services at a single location—a design element Rowan believes is central to ensuring women receive care and attention of the highest quality.

“Imagine a wellness center for women where you know you’re getting the best care, where all of the best doctors are focused on you and every interaction comes from a place of caring,” says Rowan, who recently made a transformational gift to establish the Rowan Center. “I was born at Mount Sinai, my children were born at Mount Sinai, and I feel so fortunate to be able to do this with them.”

Rowan joined Mount Sinai’s Board of Trustees in 2023, crediting the decision to her lifelong fascination with health care, medicine, and wellness. That passion shows in her motivation to educate women from a young age on how to optimally care for their bodies. A philosophy of prevention will be primary to the Rowan Center and made possible in part through research, one of the foundational pillars on which Mount Sinai stands. The Blavatnik Family Women’s Health Research Institute and the newly established Women’s Biomedical Research Institute conduct basic and translational research specific to the biology of women’s health across the lifespan, and each will directly inform care at the Rowan Center.

Rowan envisions a colocation of providers who are at the top of their practice in every area of women’s health, making the Rowan Center a premier destination for the women of New York City. Not only will the convenience of accessing multiple services at the same hospital lower barriers to care, but such proximity will naturally empower provider collaboration, improving health outcomes while giving every patient certainty that care is centered on them. A range of women’s health services will be available at the 99th and Madison location, and the Rowan Center will anchor additional women’s health services provided across the Mount Sinai Health System, working intimately with the Raquel and Jaime Gilinski Department of Obstetrics, Gynecology and Reproductive Science at Mount Sinai to deliver the highest level of patient-centered care.

Carolyn Rowan

Moreover, Rowan is enthusiastic about an infusion of integrative medicine that will give patients access to services that are typically spread across disparate offices, if available at all. By bridging practices with roots in Western as well as Eastern systems, from precision diagnostic testing, bone density testing, and pelvic floor physical therapy to acupuncture, massage, and use of medicinal herbs, the Rowan Center will expand the range of care options such that care can be personalized to an individual patient at any stage of life.

The Rowan Center will offer specialized menopause services attuned to the needs of those in midlife, with experts proactively providing care that keeps a woman feeling her best in the years before, during, and after menopause. Menopause “is not a sexy subject,” Rowan acknowledges, and so “it has been a largely dark conversation that’s recently come to light. Mount Sinai can be the foremost in that space.”

Tying it all together will be a team of dedicated patient navigators, who will be available to help patients schedule appointments as well as manage coordination of care for those following more complex treatment plans.

Rowan hopes that her gift to establish the Rowan Center will give women “something that’s just for them,” a place where they will be heard, treated compassionately, and receive recommendations specific to the female body, whether for screenings, self-care, or exercise. Most of all, she hopes to give women peace of mind, knowing they are in a place designed to help them be healthy.

“It’s great to have something you envision come to life…and I’m only one small piece. Caring faculty and staff will be the superstars who make this happen.”

 –Carolyn Rowan

Paws & Play Facility Dog Program Hires New Pup

Oct 31, 2024 | Featured

The Paws & Play Team is growing by four paws! We are proud to say we were the first hospital in New York State—and one of the first in the nation—to feature a facility dog program in our Child Life and Creative Arts Therapy Department at the Mount Sinai Kravis Children’s Hospital. Every day since Paws & Play was established in 2017, our very first facility dog, Professor, and his four-legged pals Amos, Moby, and now Summer have been hard at work providing animal-assisted therapy (AAT) as an essential part of pediatric care. Pioneering research conducted by our clinicians has proved its beneficial effect on physical and emotional health. Not only do these loveable dogs bring much-needed comfort and joy to our youngest and most vulnerable patients, they also offer support for our physicians, nurses, and other frontline workers who often struggle with extreme stress and exhaustion.

This summer, our Paws & Play program welcomed a new employee: Summer! Summer, a 14-month old Labrador and golden retriever mix is named after a character in the TV series Yellowstone. She recently graduated from a bond-based training program through Canine Assistants, and works with her primary handler Bethany Pincus, MA, LCAT, MT-BC, in our medical surgical unit and step-down unit, as well as with secondary handler Kaleigh Bieling, CCLS, in the pediatric intensive care unit (PICU) and pediatric cardiac intensive care unit (PCICU). Summer lives with Bethany on the Upper East Side of Manhattan and enjoys snacks and getting to know her new friends.

Support our Paws & Play Pups
Follow Paws & Play on Instagram

A Family’s Gifts to Nursing Education, Celebrating 120 Years of the Phillips School of Nursing

Oct 15, 2024 | Featured

Carol Phillips Green and her daughter, Janet Green

This year, as the Phillips School of Nursing celebrates its 120th anniversary, one family’s enduring legacy of support shines brighter than ever before. The Phillips-Green family has a multigenerational connection to Mount Sinai and its mission of providing health care and education to underserved communities. In the 1880’s, the Lower East Side was home to nearly a quarter of a million Jews and other immigrants living in one square mile. Moses Phillips, along with 39 other immigrants, met to discuss the need for health care for community members who did not meet the residency requirements imposed by local hospitals. At that time, most of the city’s hospitals would not treat patients who had been in the city for less than a year. The 40 immigrants each contributed 25 cents to establish the first Beth Israel Dispensary, which opened on Madison Street in 1890.

Very quickly, the demand for services grew and the recruitment of nurses became a necessity. In 1902, the Beth Israel School of Nursing was founded, and in 1904 the school was accredited by the New York Board of Regents as an educational institution. At that time, nurses in training also provided service at the hospital.

As the dispensary rapidly outgrew its cramped quarters, Moses’ son, Isaac, led a building committee to raise money for a new hospital building and in 1922, Isaac Phillips laid the cornerstone for a new Beth Israel Hospital at East 16th Street. Isaac’s son Seymour Phillips continued the family’s commitment to both the hospital and the school of nursing and in 1984, the school was named in his honor because it was Seymour who fought to keep the school open in the 1980s when it was in danger of being closed for lack of funding.

Mount Sinai Philips School of Nursing building

“The story of the Phillips School of Nursing is that of immigrants serving their new community of other immigrants,” said Seymour’s granddaughter, Janet Green. “At first they donated energy and ideas and vision. It was what they could afford to do. Later, when they could do more in the realm of major philanthropy, Seymour and his wife Madelyn; my mom Carol; and my uncle Lawrence, gave generously, quietly, and without fanfare.”

Janet’s mother, Carol Green, continued this family tradition of support until her passing at the age of 91. Throughout her lifetime, Carol was instrumental in the school’s growth and success, joining the hospital’s Board of Trustees in 1988. She became a powerful advocate for the Phillips School of Nursing, carrying her father’s torch to ensure its sustainability and prominence over the years. With her brother Lawrence, Carol established a scholarship fund to benefit nursing students. But perhaps one of the most significant acknowledgements of Carol’s commitment was reflected in her decision to include a meaningful contribution to the school in her estate plans, thereby supporting the school beyond her lifetime. And Carol’s bequest coincides with a milestone moment for the school.

“My mother’s tie to Beth Israel, which is now part of Mount Sinai, was one of family history and heart,”

says Janet, now Co-Chair of the Board of PSON. Honoring her mother’s memory and their family’s bonds to PSON spanning three centuries, Janet recently established a new nursing scholarship. With this gift, she hopes to inspire others to support the Phillips School of Nursing during this special anniversary year.

“Health care and health care education have tethered my family’s giving for over a century. Philanthropy as a family project is something people can really be proud of.”

Getting to the Heart of Comorbidities

Sep 15, 2024 | Featured

How do additional diseases affect the Cardiovascular System? The Cardiovascular Research Institute (CVRI) at Mount Sinai Fuster Heart Hospital is dedicated to uncovering how the heart and circulatory system function within the body’s interconnected systems. Before a group of our philanthropic supporters, CVRI scientific experts recently shared updates on their groundbreaking research aimed at understanding how various medical conditions place stress on the heart and vascular system, ultimately helping improve outcomes for patients with complex heart disease.

With the generous support of our donors, CVRI is revolutionizing our understanding of the intricate connections between diseases like diabetes and kidney disease; and how viral infection reveals how inflammation and metabolism drive cardiovascular complications. With advancements in precision medicine, we aim to develop targeted treatments that address these root issues, minimizing side effects and optimizing patient outcomes.

Filip Swirski, PhD
Director, Cardiovascular Research Institute
Arthur and Janet C. Ross Professor of Medicine (Cardiology)
Professor of Diagnostic, Molecular and Interventional Radiology
Icahn School of Medicine at Mount Sinai

 

As we age, it’s inevitable that we accumulate more health issues, or what we call comorbidities. Some of these conditions may exist side by side without affecting each other—chronic back pain, for example, typically doesn’t impact asthma or depression. But what we’re discovering is that many diseases do interact and influence each other, particularly in the context of cardiovascular health. There is growing evidence linking heart disease to conditions like cancer (a field known as cardio-oncology), inflammatory bowel disease, neurodegenerative diseases such as Alzheimer’s, and of course, classic risk factors like obesity, diabetes, and hypertension. The question we’re trying to answer is why these links exist—how do these diseases “talk” to one another?

Several systems seem to connect these comorbidities at a biological level. For instance, the immune system and its inflammatory responses appear to play a central role, as does metabolism. The circulatory, hematopoietic (blood-forming), endocrine, and even nervous systems might also facilitate these connections. Our work at the Cardiovascular Research Institute dives into the cellular and molecular mechanisms behind these links. By understanding how inflammation, metabolic activity, and other systemic responses drive the interaction between diseases, we’re aiming to unlock new approaches to treatment. This research has far-reaching implications, from developing therapies that target specific pathways to potentially mitigating the cascade of health issues that often accompanies aging.

One of our projects focuses on how influenza infections exacerbate heart disease. We’ve observed that people with the flu have a significantly higher risk of heart attack or heart failure, especially if they already have underlying cardiovascular issues. Our findings suggest that influenza exploits circulating immune cells, which act as Trojan horses, delivering the virus directly to the heart. This discovery points to inflammation as a key factor in viral-induced heart damage, and we’re now exploring ways to allow the immune system to combat the virus in the lungs while protecting the heart. The ultimate goal is precision medicine—targeted interventions that can limit the damage from comorbidities without broad, unintended effects. This precision approach could transform how we manage these interconnected diseases, improving outcomes by treating the root causes at a molecular level.

Leigh Goedeke, PhD
Assistant Professor, Medicine, Cardiology, Endocrinology, Diabetes and Bone Disease
Icahn School of Medicine at Mount Sinai

In my lab, we’re deeply focused on understanding how dysregulated metabolism contributes to chronic diseases, especially diabetes and cardiovascular disease. When I talk about metabolism, I mean the complex, life-sustaining chemical reactions that convert nutrients from our diet—carbohydrates, proteins, and fats—into energy or molecules our cells need. This process is highly regulated within our cells and at a broader level to maintain health, but when it’s dysregulated, it can lead to conditions like diabetes. In type 1 diabetes, the body can’t produce insulin, whereas, in type 2 diabetes, our cells become resistant to insulin, which leads to high blood sugar levels over time. This is critical because type 2 diabetes, affecting millions in the U.S., significantly raises the risk of cardiovascular issues such as heart attacks, heart failure, and stroke.

We’re particularly interested in how various risk factors in type 2 diabetes—such as high blood pressure, cholesterol, and inflammation—contribute to cardiovascular disease. Beyond this, we’ve observed that metabolic changes in specific tissues like the liver and heart can exacerbate cardiovascular risks. For example, fat accumulation and dysfunctional mitochondria in the liver can lead to excess glucose and lipid production, which raises blood sugar and promotes atherosclerosis. Additionally, we’ve identified certain harmful signaling metabolites generated by dysfunctional mitochondria in the liver that not only trigger local insulin resistance and inflammation but also travel through the bloodstream to affect other organs, including the heart. By collaborating with scientists across the CVRI, we’re exploring how these circulating metabolites might predict cardiovascular risks in patients with diabetes and testing how they drive inflammation and damage in different organs.

One exciting avenue we’re pursuing is an oral compound known as a controlled metabolic accelerator, which mimics a natural process called mitochondrial uncoupling. In our animal studies, this compound has shown promising results: it leads to fat-specific weight loss, improves glycemic control and insulin resistance, and reduces cardiovascular disease in models of obesity. By digging into the mechanisms of how this compound works, we hope to develop new treatment options that can address both diabetes and cardiovascular disease more effectively. The collaboration and integration of different expertise at CVRI allow us to study these interconnected processes holistically, aiming for breakthroughs that can truly transform patient outcomes.

Susmita Sahoo, PhD
Associate Professor, Medicine, Cardiology
Icahn School of Medicine at Mount Sinai

In my lab, we focus on understanding why patients with type 1 diabetes and those with advanced kidney disease are so prone to developing heart failure. These individuals experience heart failure at much higher rates than others, often succumbing to it rather than their primary illness. This phenomenon is not fully understood by clinicians, who currently lack treatments specifically for the heart complications in these patients. To investigate, we collaborate with nephrologists and endocrinologists to gather blood samples from hundreds of patients, comparing these with samples from healthy individuals. Our goal is to examine molecules within the blood that may explain why these patients develop heart failure, using heart cells in lab conditions to observe the impacts of disease-specific particles.

A critical focus is on extracellular vesicles (EVs) found in everyone’s blood, which act as molecular couriers. In our research, we’ve found that EVs from patients with kidney disease or diabetes carry damaging microRNAs from affected organs to the heart, influencing heart cells negatively. Using advanced sequencing, we analyze these microRNAs to identify which ones cause specific damage, whether in cultured heart cells or in live animal models. By pinpointing harmful microRNAs, we hope to develop diagnostic tools that can detect heart failure risk early—before symptoms appear. Additionally, this research paves the way for treatments tailored specifically to heart failure in patients with kidney disease or type 1 diabetes.

Our goal is to move towards precision medicine by developing diagnostics and therapies that target disease-specific factors, potentially more effective than general treatments like statins or SGLT2 inhibitors. We’re excited about the possibility of eventually partnering with pharmaceutical companies to bring these targeted therapies and diagnostic kits to clinical use. This work is possible thanks to a multidisciplinary effort, involving data scientists and lab teams who assist in processing and analyzing extensive data, with the supportive, collaborative environment at CVRI allowing us to push the boundaries in understanding and treating these complex heart conditions.

Learn more about the exciting work of the CVRI and how you can get involved

UN Week 2024: Philanthropy Fueling Global Impact in Guyana and Nepal

Updated on Nov 21, 2024 | Featured

In late September, Rachel Vreeman, MD, MS, Chair of the Department of Health System Design and Global Health at Icahn School of Medicine at Mount Sinai and Brendan G. Carr, MD, MS, Chief Executive Officer and Professor and Kenneth L. Davis Distinguished Chair of the Mount Sinai Health System, appeared with the President of Guyana and the Prime Minister of Nepal during the UN General Assembly and the Concordia Summit. Under the direction of Dr. Vreeman, Mount Sinai’s Arnhold Institute for Global Health partners with both countries’ health systems via strategic partnerships, including faculty, staff, medical student and resident exchange opportunities; and joint scientific research and quality improvement projects.

Spotlight on Guyana

In July 2022, the President of Guyana, His Excellency Dr. Irfaan Ali, announced a new national health care initiative in collaboration with the Mount Sinai Health System and Hess Corporation to improve the quality of and access to health care for the people of Guyana. Working with the government of Guyana, the Mount Sinai team partners to develop high quality primary care, specialized services in cardiology and oncology, and significant improvements at the Georgetown Public Hospital Corporation.

The work is funded jointly by the Government of Guyana and by the Hess Corporation as an extension of Mount Sinai Trustee John Hess’s philanthropic commitment to Mount Sinai. As Mr. Hess shared at the September 24th Concordia Summit, his company has a core value of social responsibility: “Making a positive social impact on the communities where we do business is something that differentiates us. It’s not just about building an economic legacy, but building a social legacy.”

Thus fueled by philanthropy, the Arnhold Institute partners directly with the Guyanese Ministry of Health and the Hess Corporation to offer vision and dental screening, treat diabetes and high blood pressure, and provide child health screenings. Facing a recent nursing shortage, the Arnhold Institute successfully increased the number of Guyanese nursing students from 400 to 1,000 by creating a hybrid learning program that includes distance learning to maximize flexibility.

The Hess family has a long-standing relationship with Mount Sinai dating back to Leon Hess’s service as a Trustee from 1966 until his death in 1999. John Hess has philanthropically supported many areas across the Health System, perhaps most notably with the lead gift to create the Leon and Norma Hess Center for Science and Medicine, which is named for his parents’ generosity and commitment to Mount Sinai and which opened in 2012 as the hub of Mount Sinai’s medical research enterprise. Mr. Hess understands how an organization like Mount Sinai can have multiple dimensions of impact, in New York City and beyond: “This is a model for developing countries where business, the government, and a health care system can work together to modernize and bring the standards of health care up in a developing country.”

Dr. Vreeman agrees on the importance of “bringing together an academic health system where we have the resources of research and clinicians, and an understanding of health systems, with a truly visionary government partner, and a corporate partner who’s willing to put forward everything that it takes.”

“It’s not only how do we build new hospitals and modernize our hospitals and make sure that we have top of the line equipment, but to also say we need to invest in primary care. We need to make sure that every child, no matter where they live in Guyana, receives a comprehensive health evaluation; that we need to put in place the data systems, the digital health infrastructure. That every single citizen—no matter how hard to reach in the region in which they live—starts to be able to access the health system in their community. They’re investing in the health workforce and investing for the next generation.”

Mount Sinai’s work in Guyana is an entirely philanthropically supported movement paid for by the Guyanese government, the Hess Corporation, and research grants from the National Institutes of Health and others. Philanthropy enabling this program will, in President Ali’s words, “ensure that we grow a healthy population… It is much more than health care provision. It is building a world-class ecosystem to support health care provision.”

Rachel Vreeman, MD, MS, Chair of the Department of Health System Design and Global Health at Icahn Mount Sinai; John B. Hess, Chief Executive Officer of Hess Corporation and Trustee of the Mount Sinai Health System; His Excellency Dr. Irfaan Ali, President of Guyana; Brendan G. Carr, MD, MS, Chief Executive Officer and Professor and Kenneth L. Davis Distinguished Chair of the Mount Sinai Health System.

Spotlight on Nepal

In 2022, the Arnhold Institute announced a multi-year agreement with the Kathmandu University School of Medical Sciences and Dhulikhel Hospital in Nepal to advance clinical education, training, research, and care. The program focuses on strategic priorities including non-communicable diseases, subspecialty care development, women’s and child health, adolescent health, and the advancement of research and education programs. It engages the Academic Model Providing Access to Health (AMPATH) Consortium, a global network of 15 universities and academic health centers that aims to improve health care in underserved communities.

In September 2024, during UN week, Mount Sinai hosted the Rt. Honorable Prime Minister Mr. K.P. Sharma Oli of Nepal. As Dr. Rachel Vreeman said on the occasion, “we will continue to transform health both for the area of Nepal in which we are working as well as here at Mount Sinai.”

In New York, Mount Sinai has a significant population of Nepalese and Guyanese diaspora students and employees. The Elmhurst Hospital Center, located in western Queens, is a major teaching affiliate of Icahn Mount Sinai and treats more Nepalese patients than any other hospital in America. Dr. Carr added to Rt. Honorable Prime Minister Oli, “The relationship with you in Nepal strengthens our knowledge about how to take meaningful care of patients at Elmhurst in New York.”

As the Rt. Honorable Prime Minister Oli was set to return home to Nepal, heavy rainfall in central Nepal, whose population is approximately 2.2 million, triggered massive flooding and landslides. More than 200 people were killed, with thousands more displaced. The Mount Sinai AMPATH Nepal program moved quickly into action, calling for our donor community to support their disaster relief efforts, and the community responded with an outpouring of gifts totaling almost $10,000. Donations made through the Arnhold Institute and AMPATH Nepal through October 31st directly supported the humanitarian response led by our partners at Dhulikhel Hospital–one of the key coordinating centers for the Government’s emergency relief efforts in Bagmati Province. Donations to the program made after that date support the AMPATH program’s continuing work in Nepal. Mount Sinai’s teams in Nepal continue to help with emergency response operations, humanitarian relief, and rebuilding efforts alongside Dhulikhel Hospital.

From celebrating the partnership with world leaders during UN Week in New York City, to mobilizing emergency response on the ground in Nepal, this fall has been a time of celebration, tragedy, and unity for the program.

 

Watch: AIGH-Nepal AMPATH Partnership Highlight Video
Donate to Mount Sinai’s AMPATH program

The Arnhold Institute for Global Health was founded in 2014 with support from The Mulago Foundation and the Arnhold Foundation, which advocates for health care, the environment, education, and international affairs. Through partnerships, the Institute has supported more than 52,000 local health care providers. Collectively, these partnerships have supported health care for 12.5 million people across three continents.

Pin It on Pinterest